Clinical Trials Directory

Trials / Completed

CompletedNCT03554525

Weight Regain After Consumption of Food Supplement and Interventional Diet Program

Clinical Trial to Evaluate the Usefulness of the Regular Consumption of a Food Supplement(FAT-BINDER DAMM) on Weight Regain After an Interventional Diet Program on Overweight/Obese People

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Instituto de Investigación Hospital Universitario La Paz · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Effect of the dietary supplement (FAT-BINDER DAMM) on weight regain after 9 months of control weight program

Detailed description

* 60 participants will consume experimental product every day 3 sticks of the dietary supplement (1.4 grams/stick) during 12 months: 2 sticks should be consumed before lunch and 1 stick before dinner. During the 12 first weeks, each volunteer will be included on a low weight program (PPP) with an individual hypocaloric diet planning and regular physical adapted activity (PPP period). When PPP period is over, volunteers will continue consuming the product for 9 months more (Post-PPP period). * 60 participants will consume everyday 3 placebo sticks (1.4 grams/stick) during 12 months: 2 sticks should be consumed before lunch and 1 stick before dinner. During the first 12 weeks, each volunteer will be included on a low weight program (PPP) with an individual hypocaloric diet planning and regular physical adapted activity (PPP period ). When PPP period is over, volunteers will continue consuming the product for 9 months more.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFat-binder damm3 sticks every day during 12 months
DIETARY_SUPPLEMENTPlacebo3 sticks every day during 12 months

Timeline

Start date
2017-04-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2018-06-13
Last updated
2019-04-17

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03554525. Inclusion in this directory is not an endorsement.